Analyst, Financial Planning and Analysis
DISCGENICS INC
Summary
The Financial Analyst is responsible for budgeting, forecasting, monthly variance analysis. In support of these activities, the Financial Analyst will work closely with the CFO and Department Heads to understand business trends and present information to Executives. In addition to this, the Financial Analyst will perform various financial or administrative duties as required to support business and financial operations.
Job description
This role interacts with all levels of the organization in a collaborative and positive way with colleagues to facilitate department and organizational initiatives for cultural cohesion aligned to the DiscGenics Values.
Essential Duties and Responsibilities
- Annual Budgeting: Lead efforts for information gathering, trend analysis, quantification of major capital and vendor expenditures, and consolidation of information for the purpose of creating an Annual Budget.
- Monthly Variance Analysis: Partner with Financial Accountant to process a roll-forward of the prior month's actuals and interpret the prior month's financial results. Make observations and recommendations about emerging spending trends and assist in correcting any errors related to account coding or financial statement accuracy.
- Forecasting: Meet with Department Heads and/or their teams on a regular basis to identify trends and process forecast updates/revisions in accordance with the latest business needs. Use business insights to make recommendations to Department Heads and Senior Executives about how to modify spending trends in support of business objectives.
- Procurement/Purchasing: Procurement related activities to ensure alignment with budget management. This includes working with Supply Chain Manager to understand purchasing dynamic, creation of Purchase Orders and routing them Approval, ensuring correct G/L account utilization, and providing input on measures to manage against the budget.
- Other: Maintain G/L account structure and mapping and make recommendations and changes to facilitate improvements in expense reporting and budget management.
- Administrative support related to Carta and communication directly with Executives and Shareholders.
- Other duties as assigned.
Requirements
- Bachelor's Degree in Finance and/or equivalent experience.
- General understanding of US GAAP reporting rules and guidelines.
- Completion of at least one annual budgeting cycle for a multi-departmental organization.
- Familiarity with ERP reporting software (experience with QuickBooks Online, NetSuite, preferred).
- Ability to interpret and use data to make recommendations.
- Demonstrated Problem-Solving skills and ability to streamline processes.
- Excellent Interpersonal Skills and ability to interact with all levels of an organization (including up to Executives).
- High integrity and ability to maintain highly confidential information.
- Exceptional time management and multi-tasking skills.
- Team leadership skills and team player.
- Adheres to and leads with the Company Values of Integrity, Innovation, Accuracy, Teamwork and Stewardship.
- Regular and predictable attendance.
- Ability to report to work responsive, free from sedatives, and in a non-sedative state.
- Proficient with Microsoft Office, including Word, Excel, and PowerPoint.
Company overview
DiscGenics Inc. is a privately held, clinical-stage biotechnology company headquartered in Salt Lake City, Utah, focused on developing innovative regenerative cell-based therapies for degenerative diseases of the spine. Founded in 2007, the company specializes in creating allogeneic cell therapies derived from intervertebral disc cells to address chronic back pain, a condition affecting millions worldwide. DiscGenics' lead product candidate, IDCT (rebonuputemcel), is an injectable disc cell therapy that utilizes proprietary Discogenic Cells to treat mild to moderate degenerative disc disease. The company has raised over $71 million in funding, including a $50 million Series C round in 2020, and is conducting concurrent clinical trials in both the United States and Japan. With a team of 11-50 employees, DiscGenics operates a state-of-the-art manufacturing facility in Utah and has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for IDCT, positioning it as a pioneer in non-surgical, potentially regenerative solutions for spinal disorders.